Table of Contents
1: EXECUTIVE SUMMARY
INTRODUCTION
SCOPE AND METHODOLOGY
SIZE AND GROWTH OF THE MARKET
Table 1-1: The Worldwide Market for Prescription Dermatological Drugs 2014-2021
ISSUES AND TRENDS AFFECTING THE MARKET
COMPETITIVE OUTLOOK
2: INTRODUCTION AND OVERVIEW
STRUCTURE AND FUNCTION OF THE SKIN
Epidermis
Dermis
Subcutaneous Tissue
Epidermal Appendages
FUNCTIONS OF THE SKIN
EFFECTS OF AGING ON THE SKIN
DERMATOLOGICAL CONDITIONS AND TREATMENT
PHARMACOKINETICS
Drug Absorption
Distribution
Bioavailability
Drug Delivery Methods
Table 2-1: Common Bases for Topical Dermatological Medications
DEMOGRAPHICS OF SKIN DISORDERS, INCIDENCE AND PREVALENCE
Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions
3: ISSUES AND TRENDS
INTRODUCTION
NEW THERAPEUTIC ERA ON HORIZON FOR ATOPIC DERMATITIS
NEW GUIDELINES FOR ROSACEA TREATMENT
PATIENT COMPLIANCE
COSMETICS DERMATOLOGISTS
SUNSCREEN USE
MELANOMA SURVIVAL RATES FALTER
NEW MELANOMA STAGING SYSTEM
INDOOR TANNING ISSUE
PHOSPHATIDYLGLYCEROL AND PSORIASIS
NEW FILLER OPTIONS
CONSUMER CONFUSION
GENETIC LINK TO PSORIASIS
BIOLOGIC DERMATOLOGY
RX-TO-OTC SWITCHES
Table 3-1: Selected Dermatological Rx-to-OTC Switches
COSMECEUTICALS
Antioxidants
Polypeptides
TELEDERMATOLOGY
REIMBURSEMENT ISSUES
MARKET SHIFT TOWARDS LESS INVASIVE PROCEDURES
MEDI-SPAS
COMBINATION THERAPIES
COMPETITIVE, ECONOMIC, SOCIAL FORCES DRIVING MARKET DEMAND
Society’s Obsession with Physical Appearance
Male Aesthetic Growth
REGULATORY INFLUENCES: US & INTERNATIONAL
International Authorities
U.S. FDA & Other Regulatory Agencies
EFFECTS OF HEALTH INSURANCE PROGRAMS & TREATMENT COSTS
COMPETITIVE INFLUENCES – IMPACT ON MARKET & TREATMENT MODALITIES
Facial Skin–Bio-Physiology
The “Gray Areas” of Medicine
LASER THERAPY
NARROWBAND ULTRAVIOLET B
PHOTODYNAMIC THERAPY
PYCR1 GENE
CHANGES IN CREDIT CARD TERMS
PATIENT PROTECTION AND AFFORDABLE CARE ACT
THERMAGE
BRAF GENE
NEW ORAL MEDICATIONS AND RESEARCH FOR ACNE
SYNTHETIC LIPIDS FOR SKIN HEALING
IMPORTANCE OF DRUG DELIVERY
PLATELET RICH PLASMA IN DERMATOLOGY
INDUSTRY CONSOLIDATION
4: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
DESCRIPTION OF DISORDERS
PRODUCT DESCRIPTION
Benzoyl Peroxide
Table 4-1: Common Benzoyl Peroxide Formulations
Retinoids
Table 4-2: Common Retinoid Formulations
Antibiotics
Table 4-3: Common Topical Antibiotic Formulations
Oral Contraceptives
Table 4-4: Common Oral Contraceptive Formulations
RESEARCH AND DEVELOPMENT
Table 4-5: Prescription Acne, Actinic Keratosis and Rosacea Formulations in Development
MARKET SIZE AND GROWTH
Worldwide Market
Table 4-6: The Worldwide Market for Prescription Acne and Rosacea Drugs by Type, 2014-2021 (Benzoyl, Retinoids, Antibiotics, Other)
Figure 4-1: The Worldwide Market for Prescription Acne and Rosacea Drugs, Share by Type, 2016 (Antibiotics, Retinoids, Benzoyl, Others)
Figure 4-2: The Worldwide Market for Prescription Acne and Rosacea Drugs, Share by Type, 2021 (Antibiotics, Retinoids, Benzoyl, Others)
Markets by Geographical Region
Table 4-7: Market Size and Growth for US Prescription Acne and Rosacea Market, 2016-2021
Table 4-8: Market Size and Growth for Europe Prescription Acne and Rosacea Market, 2016-2021
Table 4-9: Market Size and Growth for Germany Prescription Acne and Rosacea Market, 2016-2021
Table 4-10: Market Size and Growth for France Prescription Acne and Rosacea Market, 2016-2021
Table 4-11: Market Size and Growth for UK Prescription Acne and Rosacea Market, 2016-2021
Table 4-12: Market Size and Growth for Italy Prescription Acne and Rosacea Market, 2016-2021
Table 4-13: Market Size and Growth for Spain Prescription Acne and Rosacea Market, 2016-2021
Table 4-14: Market Size and Growth for Other European Prescription Acne and Rosacea Market, 2016-2021
Table 4-15: Market Size and Growth for Japan Prescription Acne and Rosacea Market, 2016-2021
Table 4-16: Market Size and Growth for ROW Prescription Acne and Rosacea Market, 2016-2021
Table 4-17: Market Size and Growth for China Prescription Acne and Rosacea Market, 2016-2021
Table 4-18: Market Size and Growth for India Prescription Acne and Rosacea Market, 2016-2021
Table 4-19: Market Size and Growth for Brazil Prescription Acne and Rosacea Market, 2016-2021
Table 4-20: Market Size and Growth for Australia Prescription Acne and Rosacea Market, 2016-2021
Table 4-21: Market Size and Growth for Other ROW Prescription Acne and Rosacea Market, 2016-2021
THE FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 4-22: Worldwide Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier, 2016
Figure 4-3: Worldwide Market for Prescription Antiacne and Rosacea Drugs, Market Share by Supplier (%), 2016
5: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
OVERVIEW
PRODUCT DESCRIPTION
Keratolytics
Table 5-1: Common Prescription Keratolytic Formulations
Moisturizers
Table 5-2: Occlusive Moisturizers – Categories of Ingredients
Table 5-3: Common Prescription Moisturizers
Retinoids
Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
Sunscreens
Table 5-5: Common Prescription Sunscreens
Botox and Fillers
Table 5-6: Other Prescription Antiaging and Photodamage Products
RESEARCH AND DEVELOPMENT
Table 5-7: Prescription Antiaging and Photodamage Formulations in Development
MARKET FORECAST AND GROWTH
Worldwide Market
Table 5-8: The Worldwide Market for Prescription Antiaging and Photodamage Drugs by Type, 2014-2021 (Keratolytics, Moisturizers, Retinoids, Sun-screens, Botox & Fillers)
Figure 5-1: The Worldwide Market for Prescription Antiaging and Photodamage Drugs, % Share by Type, 2016 (Fillers, Sunscreen, Retinoids, Moisturizer, Kerolytics)
Figure 5-2: The Worldwide Market for Prescription Antiaging and Photodamage Drugs, % Share by Type, 2021 (Fillers, Sunscreen, Retinoids, Moisturizer, Kerolytics)
Markets by Geographical Region
Table 5-9: Market Size and Growth for US Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-10: Market Size and Growth for Europe Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-11: Market Size and Growth for Germany Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-12: Market Size and Growth for France Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-13: Market Size and Growth for UK Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-14: Market Size and Growth for Italy Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-15: Market Size and Growth for Spain Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-16: Market Size and Growth for Other European Regions, Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-17: Market Size and Growth for Japan Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-18: Market Size and Growth for Rest of World Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-19: Market Size and Growth for China Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-20: Market Size and Growth for India Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-21: Market Size and Growth for Brazil Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-22: Market Size and Growth for Australia Prescription Antiaging and Photodamage Market, 2016-2021
Table 5-23: Market Size and Growth for Rest of World Prescription Antiaging and Photodamage Market, 2016-2021
Figure 5-3: The Worldwide Prescription Antiaging and Photodamage Market by Region (US, Europe, Japan, ROW), 2016 (%)
Figure 5-4: The Worldwide Prescription Antiaging and Photodamage Market by Region (US, Europe, Japan, ROW), 2021 (%)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 5-24: Worldwide Market for Prescription Antiaging and Photodamage Drugs, Revenues and Market Share by Supplier, 2016
Figure 5-5: Worldwide Market for Prescription Antiaging and Photodamage Drugs, Percent Market Share by Supplier (%), 2016
6: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
OVERVIEW
DESCRIPTION OF PRODUCTS
Topical Corticosteroids
Table 6-1: Common Prescription Topical Corticosteroid Preparations
Systemic Corticosteroids
Table 6-2: Common Prescription Systemic Corticosteroids
Other Products
Table 6-3: Prescription Other Dermatitis Formulations
RESEARCH AND DEVELOPMENT
Table 6-4: Prescription Dermatitis Formulations in Development
MARKET FORECAST AND GROWTH
Worldwide Market by Type
Table 6-5: The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type, 2016-2021 (Topical, Systemic, Other)
Figure 6-1: The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, % Share by Type, 2016 (Topical, Systemic, Other)
Figure 6-2: The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, % Share by Type, 2021 (Topical, Systemic, Other)
Markets by Geographical Region
Table 6-6: Market Size and Growth for US Market for Prescription Dermatitis and Seborrhea Drugs, 2016-2021
Table 6-7: Market Size and Growth for Europe Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-8: Market Size and Growth for France Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-9: Market Size and Growth for Italy Prescription Dermatitis and Seborrhea Market, 2016-2021 .. 156
Table 6-10: Market Size and Growth for Germany Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-11: Market Size and Growth for Spain Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-12: Market Size and Growth for UK Prescription Dermatitis and Seborrhea Market, 2016-2021 .. 157
Table 6-13: Market Size and Growth for Other European Region, Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-14: Market Size and Growth for Japan Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-15: Market Size and Growth for Rest of World Market Prescription Dermatitis and Seborrhea, 2016-2021
Table 6-16: Market Size and Growth for China Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-17: Market Size and Growth for India Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-18: Market Size and Growth for Brazil Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-19: Market Size and Growth for Australia Prescription Dermatitis and Seborrhea Market, 2016-2021
Table 6-20: Market Size and Growth for Rest of World Prescription Dermatitis and Seborrhea Market, 2016-2021
Figure 6-3: The Worldwide Prescription Dermatitis and Seborrhea Market by Region (US, Europe, Japan ROW), 2016 (%)
Figure 6-4: The Worldwide Prescription Dermatitis and Seborrhea Market by Region (US, Europe, Japan, ROW), 2021 (%)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 6-21: Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, Revenues and Market Share by Supplier, 2016
Figure 6-5: Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, Percent Market Share by Supplier, 2016
7: PRESCRIPTION ANTIFUNGAL DRUGS
OVERVIEW
PRODUCT DESCRIPTION
Systemic Formulations
Topical Formulations
Allylamines and Benzylamines
Other Topical Formulations
Novel Products
RESEARCH AND DEVELOPMENT
Table 7-1: Prescription Antifungal Formulations in Development
MARKET SIZE AND GROWTH
Worldwide Market by Type
Table 7-2: The Worldwide Market for Prescription Antifungal Drugs by Type, 2014-2021 (Topical, Systemic)
Figure 7-1: The Worldwide Market for Prescription Antifungal Drugs by Type (%), 2016 (Systemic, Topical)
Figure 7-2: The Worldwide Market for Prescription Antifungal Drugs by Type (%), 2021 (Systemic, Topical)
Markets by Geographical Region
Table7-3: Market Size and Growth for US Prescription Antifungal Drug Market, 2016-2021
Table 7-4: Market Size and Growth for Europe Antifungal Drug Market, 2016-2021
Table 7-5: Market Size and Growth for Germany Antifungal Drug Market, 2016-2021
Table 7-6: Market Size and Growth for France Antifungal Drug Market, 2016-2021
Table 7-7: Market Size and Growth for UK Antifungal Drug Market, 2016-2021
Table 7-8: Market Size and Growth for Italy Antifungal Drug Market, 2016-2021
Table 7-9: Market Size and Growth for Spain Antifungal Drug Market, 2016-2021
Table 7-10: Market Size and Growth for Other European Regions Antifungal Drug Market, 2016-2021
Table 7-11: Market Size and Growth for Japan Antifungal Drug Market, 2016-2021
Table 7-12: Market Size and Growth for ROW Antifungal Drug Market, 2016-2021
Table 7-13: Market Size and Growth for China Antifungal Drug Market, 2016-2021
Table 7-14: Market Size and Growth for India Antifungal Drug Market, 2016-2021
Table 7-15: Market Size and Growth for Brazil Antifungal Drug Market, 2016-2021
Table 7-16: Market Size and Growth for Australia Antifungal Drug Market, 2016-2021
Table 7-17: Market Size and Growth for Rest of World Antifungal Drug Market, 2016-2021
Figure 7-3: The Worldwide Antifungal Drug Market by Region (US, Europe, Japan, ROW), 2016 (%)
Figure 7-4: The Worldwide Antifungal Drug Market by Region (US, Europe, Japan, ROW), 2021 (%)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 7-18: Worldwide Market for Prescription Antifungal Drug Revenues and Market Share by Supplier, 2016
The Worldwide Market for Prescription Dermatological Drugs
June viii 2017 © Kalorama Information
Figure 7-5: Worldwide Market for Prescription Antifungal Drug Revenues and Market Share by Supplier (%), 2016
8: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
OVERVIEW
PRODUCT DESCRIPTION
Antiandrogens
Androgen Inhibitors
Other Treatments
Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
RESEARCH AND DEVELOPMENT
Table 8-2: Prescription Hair Loss and Hair Removal Formulations in Development
MARKET FORECAST AND GROWTH
Worldwide Market by Type
Table 8-3: The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type, 2014-2021 (Antiandrogens, Androgen Inhibitors, Others)
Figure 8-1: The Worldwide Prescription Hair Loss and Hair Removal Drug Market Share by Type (%), 2016 (Androgen Inhibitors, Antiandrogens, Others)
Figure 8-2: The Worldwide Prescription Hair Loss and Hair Removal Drug Market Share by Type (%), 2021 (Androgen Inhibitors, Antiandrogens, Others)
Markets by Geographical Region
Table 8-4: Market Size and Growth for US Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-5: Market Size and Growth for Europe Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-6: Market Size and Growth for the Germany Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-7: Market Size and Growth for the France Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-8: Market Size and Growth for the UK Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-9: Market Size and Growth for the Italy Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-10: Market Size and Growth for the Spain Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-11: Market Size and Growth for the Other European Regions, Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-12: Market Size and Growth for the Japan Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-13: Market Size and Growth for the Rest of World Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-14: Market Size and Growth for the China Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-15: Market Size and Growth for the India Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-16: Market Size and Growth for the Brazil Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-17: Market Size and Growth for the Russia Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Table 8-18: Market Size and Growth for the Rest of World Prescription Hair Loss and Hair Removal Drug Market, 2016-2021
Figure 8-3: The Worldwide Prescription Hair Loss and Hair Removal Drug Market by Region (US, Europe, Japan, ROW), 2016 (%)
Figure 8-4: The Worldwide Prescription Hair Loss and Hair Removal Drug Market by Region (US, Europe, Asia/ROW), 2021 (%)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 8-19: Worldwide Market for Prescription Hair Loss and Hair Removal Revenues and Market Share by Supplier, 2016
Figure 8-5: Worldwide Market for Prescription Hair Loss and Hair Removal Drug Revenues and Market Share by Supplier (%), 2016
9: PRESCRIPTION HYPERPIGMENTATION/MELASMA AND DEPIGMENTING DRUGS
OVERVIEW
PRODUCT DESCRIPTION
Table 9-1: Common Prescription Hyperpigmentation/Melasma
Table 9-2: Common Prescription Depigmenting Agents
RESEARCH AND DEVELOPMENT
Table 9-3: Prescription Hyperpigmentation/ Melasma/ Depigmenting Formulations in Development
MARKET FORECAST AND GROWTH
Worldwide Market
Table 9-4: The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type, 2014-2021 (Hyperpigmentation/Melasma, Depigmenting)
Figure 9-1: The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs, Share by Type (%), 2016
Figure 9-2: The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs, Share by Type (%), 2021
Markets by Geographical Region
Table 9-5: Market Size and Growth for US Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-6: Market Size and Growth for Europe Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-7: Market Size and Growth for Germany Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-8: Market Size and Growth for France Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
The Worldwide Market for Prescription Dermatological Drugs
June x 2017 © Kalorama Information
Table 9-9: Market Size and Growth for UK Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-10: Market Size and Growth for Italy Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-11: Market Size and Growth for Spain Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-12: Market Size and Growth for Other European Regions Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-13: Market Size and Growth for Japan Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-14: Market Size and Growth for China Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-15: Market Size and Growth for India Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-16: Market Size and Growth for Brazil Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-17: Market Size and Growth for Russia Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Table 9-18: Market Size and Growth for ROW Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market, 2016-2021
Figure 9-3: The Worldwide Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market by Region (US, Europe, Japan, ROW), 2016 (%)
Figure 9-4: The Worldwide Prescription Hyperpigmentation/Melasma and Depigmenting Drug Market by Region (US, Europe, Japan, ROW), 2021 (%)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
10: PRESCRIPTION PSORIASIS DRUGS
OVERVIEW
PRODUCT DESCRIPTION
Selected Topical Psoriasis Products
Methoxsalen
Selected Systemic Psoriasis Preparations
Table 10-1: Selected Prescription Psoriasis Preparations
Light Therapy
Biologics
Table 10-2: Prescription Biologics for Psoriasis Treatment
Novel Products
RESEARCH AND DEVELOPMENT
Table 10-3: Prescription Psoriasis Formulations in Development
MARKET FORECAST AND GROWTH
Worldwide Market by Type
Table 10-4: The Worldwide Market for Prescription Psoriasis Drugs by Type, 2014-2021 (Topical, Systemic, Others)
Figure 10-1: The Worldwide Market for Prescription Psoriasis Drugs, Share by Type (%), 2016 (Topical, Systemic, Others)
Figure 10-2: The Worldwide Market for Prescription Psoriasis Drugs, Share by Type (%), 2021 (Topical, Systemic, Others)
Markets by Geographical Region
Table 10-5: Market Size and Growth for US Prescription Psoriasis Drug Market, 2016-2021
Table 10-6: Market Size and Growth for Europe Prescription Psoriasis Drug Market, 2016-2021
Table10-7: Market Size and Growth for Germany Prescription Psoriasis Drug Market, 2016-2021
Table 10-8: Market Size and Growth for France Prescription Psoriasis Drug Market, 2016-2021
Table 10-9: Market Size and Growth for UK Prescription Psoriasis Drug Market, 2016-2021
Table 10-10: Market Size and Growth for Italy Prescription Psoriasis Drug Market, 2016-2021
Table 10-11: Market Size and Growth for Spain Prescription Psoriasis Drug Market, 2016-2021
Table 10-12: Market Size and Growth for Other European Regions Prescription Psoriasis Drug Market, 2016-2021
Table 10-13: Market Size and Growth for Japan Prescription Psoriasis Drug Market, 2016-2021
Table 10-14: Market Size and Growth for India Prescription Psoriasis Drug Market, 2016-2021
Table 10-15: Market Size and Growth for China Prescription Psoriasis Drug Market, 2016-2021
Table 10-16: Market Size and Growth for Brazil Prescription Psoriasis Drug Market, 2016-2021
Table 10-17: Market Size and Growth for Australia Prescription Psoriasis Drug Market, 2016-2021
Table 10-18: Market Size and Growth for ROW Prescription Psoriasis Drug Market, 2016-2021
Figure 10-3: The Worldwide Market for Prescription Psoriasis Drugs, Share by Region (US, Europe, Japan, ROW), 2016 (%)
Figure 10-4: The Worldwide Market for Prescription Psoriasis Drugs, Share by Region, (US, Europe, Japan, ROW), 2021 (%)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 10-19: Worldwide Market for Prescription Psoriasis Drugs, Revenues and Market Share by Supplier, 2016
Figure 10-5: Worldwide Market for Prescription Psoriasis Drugs, Percent Market Share by Supplier, 2016
11: PRESCRIPTION SKIN CANCER DRUGS
OVERVIEW
Nonmelanoma Skin Cancers
Table 11-1: Malignant Conditions of the Skin
Malignant Melanoma
PRODUCT DESCRIPTION
5-Fluorouracil
Mechlorethamine/Nitrogen Mustard
Carmustine/BCNU (Topical)
Vinblastine (Intralesional) and Others
Table 11-2: Common Prescription Topical, Intralesional and Other Skin Cancer Agents
RESEARCH AND DEVELOPMENT
Table 11-3: Prescription Skin Cancer Preparations in Development
MARKET SIZE AND GROWTH
Worldwide Market
Table 11-4: Worldwide Market for Skin Cancer Drugs, 2014-2021
Markets by Geographical Region
Table 11-5: Market Size and Growth for US Prescription Skin Cancer Drug Market, 2016-2021
Table 11-6: Market Size and Growth for Europe Prescription Skin Cancer Drug Market, 2016-2021
Table 11-7: Market Size and Growth for Germany Prescription Skin Cancer Drug Market, 2016-2021
Table 11-8: Market Size and Growth for France Prescription Skin Cancer Drug Market, 2016-2021
Table 11-9: Market Size and Growth for UK Prescription Skin Cancer Drug Market, 2016-2021
Table 11-10: Market Size and Growth for Italy Prescription Skin Cancer Drug Market, 2016-2021
Table 11-11: Market Size and Growth for Spain Prescription Skin Cancer Drug Market, 2016-2021
Table 11-12: Market Size and Growth for Other European Regions Prescription Skin Cancer Drug Market, 2016-2021
Table 11-13: Market Size and Growth for Japan Prescription Skin Cancer Drug Market, 2016-2021
Table 11-14: Market Size and Growth for China Prescription Skin Cancer Drug Market, 2016-2021
Table 11-15: Market Size and Growth for India Prescription Skin Cancer Drug Market, 2016-2021
Table 11-16: Market Size and Growth for Brazil Prescription Skin Cancer Drug Market, 2016-2021
Table 11-17: Market Size and Growth for Australia Prescription Skin Cancer Drug Market, 2016-2021
Table 11-18: Market Size and Growth for ROW Prescription Skin Cancer Drug Market, 2016-2021
Figure 11-1: The Worldwide Skin Cancer Drug Market, Percent Market Share by Geographic Region, 2016 (US, Europe, Japan, ROW)
Figure 11-2: The Worldwide Skin Cancer Drug Market, Percent Market Share by Geographic Region, 2021 (US, Europe, Japan, ROW)
FUTURE OF THE MARKET
COMPETITIVE ANALYSIS
Table 11-19: Worldwide Market for Prescription Skin Cancer Drugs, Revenues and Market Share by Supplier, 2016
Figure 11-3: Worldwide Market for Prescription Skin Cancer Drugs, Market Share by Supplier, 2016
12: MISCELLANEOUS SKIN DISORDER DRUGS
OVERVIEW
Antivirals
Antiparasitics
Others
PRODUCT DESCRIPTION
Antivirals
Current Suppliers
Table 12-1: Common Prescription Dermatological Systemic and Topical Antiviral Formulations
Current Suppliers
Table 12-2: Common Prescription Topical Antiparasitic Formulations
OTHER SKIN RELATED PRODUCTS
Table 12-3: Common Prescription Other Skin Formulations
RESEARCH AND DEVELOPMENT
Table 12-4: Prescription Miscellaneous Skin Preparations in Development
MARKET SIZE AND GROWTH
Worldwide Market
Table 12-5: The Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type, 2014-2021 (Antiviral, Antiparasitic, Others)
Markets by Geographical Region
Table 12-6: Market Size and Growth for US Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-7: Market Size and Growth for Europe Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-8: Market Size and Growth for Germany Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-9: Market Size and Growth for France Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-10: Market Size and Growth for UK Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-11: Market Size and Growth for Italy Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-12: Market Size and Growth for Spain Prescription Miscellaneous Skin Disorder Market, 2016-2021
Table 12-13: Market Size and Growth for Other European Regions Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-14: Market Size and Growth for Japan Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-15: Market Size and Growth for China Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-16: Market Size and Growth for South Korea Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-17: Market Size and Growth for Brazil Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-18: Market Size and Growth for Russia Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Table 12-19: Market Size and Growth for ROW Prescription Miscellaneous Skin Disorder Drug Market, 2016-2021
Future of the Market
COMPETITIVE ANALYSIS
13: WORLD MARKET SUMMARY
OVERVIEW
MARKET SIZE AND GROWTH
Table 13-1: The Worldwide Market for Prescription Dermatological Drugs, 2014-2021
MARKET ANALYSIS BY GEOGRAPHICAL REGION
United States
Table 13-2: United States Prescription Dermatological Drug Market, 2016-2021
Europe
Table 13-3: Europe Prescription Dermatological Drug Market, 2016-2021
Table 13-4: Germany Prescription Dermatological Drug Market, 2016-2021
Table 13-5: France Prescription Dermatological Drug Market, 2016-2021
Table 13-6: UK Prescription Dermatological Drug Market, 2016-2021
Table 13-7: Italy Prescription Dermatological Drug Market, 2016-2021
Table 13-8: Spain Prescription Dermatological Drug Market, 2016-2021
Table 13-9: Other European Regions Prescription Dermatological Drug Market, 2016-2021
Japan
Table 13-10: Japan Prescription Dermatological Drug Market, 2016-2021
Rest of World
Table 13-11: ROW Prescription Dermatological Drug Market, 2016-2021
Table 13-12: China Prescription Dermatological Drug Market, 2016-2021
Table 13-13: India Prescription Dermatological Drug Market, 2016-2021
Table 13-14: Brazil Prescription Dermatological Drug Market, 2016-2021
Table 13-15: ROW Prescription Dermatological Drug Market, 2016-2021
MARKET AND COMPETITIVE ANALYSIS
Table 13-16: Worldwide Market for Prescription Dermatological Drugs, Revenues and Market Share by Supplier, 2016
14: CORPORATE PROFILES
ABBVIE, INC
Table 14-1: AbbVie Corporate Summary
Company Overview
Company Financials
Table 14-2: AbbVie, Inc. Revenues (2013-2016)
ALLERGAN
Table 14-3: Allergan Corporate Summary
Company Overview
Company Financials
Table 14-4: Allergan Revenues (2013-2016)
ALMIRALL, S.A.
Table 14-5: Almirall Corporate Summary
Company Overview
Company Financials
Table 14-6: Almirall Revenues (2013-2016)
AMGEN, INC
Table 14-7: Amgen Corporate Summary
Company Overview
Company Financials
Table 14-8: Amgen, Inc. Revenues (2013-2016)
ANACOR PHARMACEUTICALS, INC
Table 14-9: Anacor Pharmaceuticals, Inc. Corporate Summary
Company Overview
ASTELLAS PHARMA, INC
Table 14-10: Astellas Pharma, Inc. Corporate Summary
Company Overview
Company Financials
Table 14-11: Astellas Pharma, Inc. Revenues (2013-2016)
BASILEA PHARMACEUTICA LTD.
Table 14-12: Basilea Pharmaceutica Corporate Summary
Company Overview
Company Financials
Table 14-13: Basilea Pharmaceutica Revenues (2013-2016)
BAYER
Table 14-14: Bayer Corporate Summary
Company Overview
Company Financials
Table 14-15: Bayer Revenues (2013-2016)
BIOFRONTERA AG
Table 14-16: Biofrontera AG Corporate Summary
Company Overview
Company Financials
Table 14-17: Biofrontera Revenues (2013-2016)
BRISTOL-MYERS SQUIBB
Table 14-18: Bristol-Myers Squibb Corporate Summary
Company Overview
Company Financials
Table 14-19: Bristol-Meyers Squibb Revenues (2013-2016)
CIPHER PHARMACEUTICALS
Table 14-20: Cipher Pharmaceuticals Corporate Summary
Company Overview
Company Financials
Table 14-21: Cipher Revenues (2013-2016)
CUTANEA LIFE SCIENCES
Table 14-22: Cutanea Life Sciences Corporate Summary
Company Overview
DERMIRA, INC.
Table 14-23: Dermira Corporate Summary
Company Overview
Company Financials
Table 14-24: Dermira Revenues (2013-2016)
GALDERMA S.A.
Table 14-25: Galderma S.A Corporate Summary
Company Overview
GENENTECH
Table 14-26: Genentech Corporate Summary
Company Overview
GLAXOSMITHKLINE PLC
Table 14-27: GlaxoSmithKline Plc Corporate Summary
Company Overview
Company Financials
Table 14-28: GlaxoSmithKline Plc. Revenues (2013-2016)
JOHNSON & JOHNSON
Table 14-29: Johnson & Johnson Corporate Summary
Company Overview
Company Financials
Table 14-30: Johnson & Johnson Revenues (2013-2016)
LEO PHARMA A/S
Table 14-31: LEO Pharma Corporate Summary
Company Overview
Company Financials
Table 14-32: LEO Pharma Revenues (2013-2016)
MARUHO CO. LTD.
Table 14-33: Maruho Corporate Summary
Company Overview
MERCK & COMPANY
Table 14-34: Merck & Company Corporate Summary
Company Overview
Company Financials
Table 14-35: Merck & Company Revenues (2013-2016)
MERZ PHARMA GMBH & CO KGAA
Table 14-36: Merz Pharma Corporate Summary
Company Overview
MYLAN N.V.
Table 14-37: Mylan Corporate Summary
Company Overview
Company Financials
Table 14-38: Mylan Revenues (2013-2016)
NOVAN, INC
Table 14-39: Novan Corporate Summary
Company Overview
NOVARTIS PHARMACEUTICALS CORPORATION
Table 14-40: Novartis Corporate Summary
Company Overview
Company Financials
Table 14-41: Novartis Revenues (2013-2016)
PFIZER, INC.
Table 14-42: Pfizer Corporate Summary
Company Overview
Company Financials
Table 14-43: Pfizer Revenues (2013-2016)
PHARMADERM
Table 14-44: PharmaDerm Corporate Summary
Company Overview
SIENNA BIOPHARMACEUTICALS, INC.
Table 14-45: Sienna Biopharmaceuticals Corporate Summary
Company Overview
SINCLAIR PHARMA PLC.
Table 14-46: Sinclair Pharma Corporate Summary
Company Overview
Company Financials
Table 14-47: Sinclair Pharma Revenues (2013-2016)
STIEFEL
Table 14-48: Stiefel Corporate Summary
Company Overview
VALEANT PHARMACEUTICALS INTERNATIONAL
Table 14-49: Valeant Pharmaceuticals Corporate Summary
Company Overview
Company Financials
Table 14-50: Valeant Revenues (2013-2016)
